Artemis Medicare Services Ltd Reports Strong FY26 Results and Dividend

Why These Results Matter

The strong double-digit growth in revenue and profits reflects positive business momentum.
The recommended dividend payout offers a direct return to shareholders, highlighting healthy cash flow and management's focus on returning value.
An unmodified auditor's opinion confirms the reliability of the reported financial figures.

Q4 and Full-Year Financial Overview

For the full fiscal year ended March 31, 2026, Artemis Medicare Services Ltd reported consolidated net profit of ₹103.72 Cr, a 26.21% increase year-over-year. Consolidated revenue grew 14.55% to ₹1,111.07 Cr.
In the fourth quarter, consolidated revenue reached ₹287.01 Cr, up 13.78% year-over-year, with a net profit of ₹30.28 Cr.

About Artemis Medicare Services

Artemis Medicare Services Ltd is a key player in India's hospital sector, operating a network of multi-specialty healthcare facilities.
The company has been expanding its services and facilities to meet the needs of an increasing number of patients across the country.

Impact for Shareholders and Operations

Shareholders can look forward to a dividend payout, which adds to potential investment returns.
The company's sustained growth indicates a positive trajectory for continued expansion within the healthcare sector.
Standalone equity has improved, strengthening the company's financial position for future growth and investments.

Key Risks and Challenges

An exceptional charge of ₹307.44 Lacs was recorded. This relates to increased gratuity and leave liabilities due to recent changes in government Labour Codes.
Standalone finance costs for FY26 were significant, totaling ₹2,694.40 Lacs, which could affect standalone profitability.

Competitive Landscape

Artemis Medicare competes with major hospital chains such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare, all vying for market share.
While Artemis reported 14.55% YoY revenue growth for FY26, competitor growth rates vary based on their expansion strategies and market focus.

Key Financial Metrics

Consolidated revenue grew by 14.55% from FY25 to FY26.
Consolidated net profit increased by 26.21% from FY25 to FY26.
Standalone total income for Q4 FY26 was ₹281.46 Cr.
Standalone finance costs were ₹2,694.40 Lacs in FY26.
Standalone total equity rose from ₹84,179.79 Lacs in Q4 FY25 to ₹93,866.77 Lacs in Q4 FY26.

What to Watch Next

Management commentary on sustaining the current growth momentum into FY27.
The long-term impact of revised labor codes on the company's cost structure.
Any planned capacity expansions or new strategic initiatives.
Progress on debt reduction or optimization of finance costs.
Competitor performance in upcoming quarters to understand market dynamics.